Afana Biotechnology Overview
- Year Founded
-
2021
- Status
-
Private
- Latest Deal Type
-
Series A
- Investors
-
13
Afana Biotechnology General Information
Description
Developer of programmable rna medicines designed to develop therapies for patients with unmet medical needs. The company's technology integrates rna engineering, precision delivery and immune programming, enabling the healthcare sector to access autoimmune disease therapies, cancer vaccines, prophylactic vaccines, respiratory syncytial virus vaccines, herpes zoster vaccines and solid tumor immunotherapies.
Contact Information
Website
www.rnalfa.comCorporate Office
- 4th Floor, Building 2, Phase II, Intelligent Technology Park
- Number 3963 Susong Road
- Hefei, Anhui 230011
- China
Corporate Office
- 4th Floor, Building 2, Phase II, Intelligent Technology Park
- Number 3963 Susong Road
- Hefei, Anhui 230011
- China
Afana Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series A) | 06-Nov-2026 | Completed | Generating Revenue | |||
| 7. Secondary Transaction - Private | 06-Jun-2025 | Completed | Generating Revenue | |||
| 6. Early Stage VC (Series A) | 11-Mar-2025 | Completed | Generating Revenue | |||
| 5. Early Stage VC | 22-Apr-2024 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 28-Nov-2023 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 24-Feb-2023 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 25-Nov-2022 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 19-Aug-2022 | Completed | Generating Revenue |
Afana Biotechnology Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Shenzhen Guozhong Venture Capital Management | Venture Capital | Minority | ||
| Anhui Lianyuan Venture Capital | Venture Capital | Minority | ||
| Hefei Innovation Technology Venture Capital | Growth/Expansion | Minority | ||
| USTC Silicon Valley | University | Minority | ||
| Anhui Capital | Asset Manager | Minority |
Afana Biotechnology FAQs
-
When was Afana Biotechnology founded?
Afana Biotechnology was founded in 2021.
-
Where is Afana Biotechnology headquartered?
Afana Biotechnology is headquartered in Hefei, China.
-
What industry is Afana Biotechnology in?
Afana Biotechnology’s primary industry is Drug Discovery.
-
Is Afana Biotechnology a private or public company?
Afana Biotechnology is a Private company.
-
What is Afana Biotechnology’s current revenue?
The current revenue for Afana Biotechnology is .
-
Who are Afana Biotechnology’s investors?
Shenzhen Guozhong Venture Capital Management, Anhui Lianyuan Venture Capital, Hefei Innovation Technology Venture Capital, USTC Silicon Valley, and Anhui Capital are 5 of 13 investors who have invested in Afana Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process